• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性心房颤动消融后的心律失常类型预测重复手术的成功率。

Arrhythmia type after persistent atrial fibrillation ablation predicts success of the repeat procedure.

机构信息

Deutsches Herzzentrum München and 1 Medizinische Klinik, Technische Universität München, Munich, Germany.

出版信息

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):609-14. doi: 10.1161/CIRCEP.111.963256. Epub 2011 Aug 19.

DOI:10.1161/CIRCEP.111.963256
PMID:21856772
Abstract

BACKGROUND

The aim of the study was to investigate whether the type of arrhythmia recurrence after ablation of persistent atrial fibrillation (AF) has an impact on the maintenance of sinus rhythm after the repeat ablation procedure.

METHODS AND RESULTS

Included were 78 consecutive patients (82% men; mean age, 61±10 years; mean left atrial diameter, 47±4 mm) with persistent AF who underwent ≥1 repeat ablation. The initial ablation procedure had consisted of pulmonary vein isolation with additional substrate modification (ablation of complex fractionated atrial electrograms [n=63] or linear lesions [n=15]). Patients presented for reablation either with persistent atrial tachycardia (AT) (group 1, n=36), persistent AF (group 2, n=37), or paroxysmal AF (group 3, n=5). The primary end point was freedom from any arrhythmia off antiarrhythmic drugs 6 and 9 months after the reablation procedure. Estimated proportions of patients reaching the primary end point were 59% for group 1, 28% for group 2, and 100% for group 3 at 6 months and 51%, 23%, and 100%, for groups 1, 2, and 3, respectively, at 9 months (P=0.002).

CONCLUSIONS

In patients presenting for a repeat procedure after ablation of persistent AF, the occurrence of AT is associated with a significantly better outcome compared with recurrent persistent AF. These results suggest that AT might be considered as a step toward sinus rhythm.

摘要

背景

本研究旨在探讨持续性心房颤动(AF)消融后心律失常复发的类型是否对重复消融后窦性节律的维持有影响。

方法和结果

纳入了 78 例连续患者(82%为男性;平均年龄 61±10 岁;平均左心房直径 47±4mm),他们均接受了≥1 次重复消融。初始消融程序包括肺静脉隔离,外加基质改良(消融复杂碎裂心房电图[ n=63]或线性病变[ n=15])。患者因持续性房性心动过速(AT)(第 1 组,n=36)、持续性 AF(第 2 组,n=37)或阵发性 AF(第 3 组,n=5)而再次接受消融。主要终点是在重复消融后 6 个月和 9 个月时,无抗心律失常药物的任何心律失常发生率。6 个月时,第 1 组、第 2 组和第 3 组的患者达到主要终点的比例分别为 59%、28%和 100%;9 个月时,第 1 组、第 2 组和第 3 组的比例分别为 51%、23%和 100%(P=0.002)。

结论

在因持续性 AF 消融后再次接受消融的患者中,AT 的发生与更好的复律结果相关。这些结果提示 AT 可能被视为窦性节律的一个步骤。

相似文献

1
Arrhythmia type after persistent atrial fibrillation ablation predicts success of the repeat procedure.持续性心房颤动消融后的心律失常类型预测重复手术的成功率。
Circ Arrhythm Electrophysiol. 2011 Oct;4(5):609-14. doi: 10.1161/CIRCEP.111.963256. Epub 2011 Aug 19.
2
A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation.一项关于在肺静脉前庭隔离术后对复杂碎裂心房电图进行消融在长期持续性心房颤动治疗中的增量作用的随机评估。
J Am Coll Cardiol. 2009 Mar 3;53(9):782-9. doi: 10.1016/j.jacc.2008.10.054.
3
Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study.使用植入式监测仪检测心律失常复发并选择早期重复导管消融治疗心房颤动的患者:一项试点研究。
Circ Arrhythm Electrophysiol. 2011 Dec;4(6):823-31. doi: 10.1161/CIRCEP.111.964809. Epub 2011 Sep 19.
4
Importance of sinus rhythm as endpoint of persistent atrial fibrillation ablation.重视窦性心律作为持续性心房颤动消融的终点。
J Cardiovasc Electrophysiol. 2013 Apr;24(4):388-95. doi: 10.1111/jce.12045. Epub 2012 Dec 17.
5
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.肥厚型心肌病患者心房颤动的导管消融:心房颤动类型决定成功率。
Kardiol Pol. 2013;71(1):17-24.
6
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.长期持续性心房颤动的导管消融:临床结果及后续心律失常的机制
J Cardiovasc Electrophysiol. 2005 Nov;16(11):1138-47. doi: 10.1111/j.1540-8167.2005.00308.x.
7
Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience.导管消融能否治愈心房颤动?药物难治性心房颤动消融的单程序治疗结果:一项 6 年多中心经验。
Europace. 2010 Feb;12(2):181-7. doi: 10.1093/europace/eup349. Epub 2009 Nov 3.
8
Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy.肺静脉隔离术后肺静脉传导恢复及房颤复发:一项关于肺静脉开口处消融与肺静脉开口外消融策略的随机试验
Am Heart J. 2006 Sep;152(3):537.e1-8. doi: 10.1016/j.ahj.2006.05.029.
9
Selective ablation or isolation of all pulmonary veins in atrial fibrillation -- when and for whom?心房颤动中所有肺静脉的选择性消融或隔离——何时进行以及适用于何人?
Kardiol Pol. 2006 Jan;64(1):26-35; discussion 36-7.
10
Pulmonary vein antral isolation and nonpulmonary vein trigger ablation without additional substrate modification for treating longstanding persistent atrial fibrillation.肺静脉房部隔离和非肺静脉触发灶消融而不进行额外的基质改良治疗长期持续性心房颤动。
J Cardiovasc Electrophysiol. 2012 Aug;23(8):806-13. doi: 10.1111/j.1540-8167.2012.02307.x. Epub 2012 Apr 17.

引用本文的文献

1
Superwide Left Atrial Circumferential Ablation for Persistent Atrial Fibrillation: A Randomized Controlled Trial.持续性心房颤动的超宽左房环周消融:一项随机对照试验
J Cardiovasc Electrophysiol. 2025 Jul;36(7):1530-1537. doi: 10.1111/jce.16700. Epub 2025 Apr 30.
2
Ten-year Follow-up Study of Patients with Persistent Atrial Fibrillation Treated by Combined Pulmonary Vein Isolation and Complex Fractionated Electrogram Ablation.持续性心房颤动患者行肺静脉隔离联合碎裂电位消融治疗的十年随访研究
Arrhythm Electrophysiol Rev. 2025 Feb 28;14:e07. doi: 10.15420/aer.2024.43. eCollection 2025.
3
Does organized atrial tachycardia after a pulmonary vein isolation-only procedure portend better outcome of repeat ablation compared to recurrent atrial fibrillation?
与复发性心房颤动相比,仅行肺静脉隔离术后出现的有组织房性心动过速是否预示着再次消融有更好的结果?
J Arrhythm. 2025 Mar 25;41(2):e70049. doi: 10.1002/joa3.70049. eCollection 2025 Apr.
4
Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial.用于持续性心房颤动个体化治疗的人工智能:一项随机对照试验。
Nat Med. 2025 Apr;31(4):1286-1293. doi: 10.1038/s41591-025-03517-w. Epub 2025 Feb 14.
5
Pulmonary Vein Isolation Followed by Biatrial Ablation of Rotational Activity in Patients with Persistent Atrial Fibrillation: Results of the Cryo-Vest Study.持续性心房颤动患者肺静脉隔离后双房旋转活动消融:冷冻背心研究结果
J Clin Med. 2024 Feb 16;13(4):1118. doi: 10.3390/jcm13041118.
6
Treatment of pathophysiologic propagation outside of the pulmonary veins in retreatment of atrial fibrillation patients: RECOVER AF study.肺静脉外病理生理传播的治疗在心房颤动患者再治疗中的作用:RECOVER AF 研究。
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad097.
7
Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation.人工智能软件使基于心电图的消融结果标准化,用于治疗持续性心房颤动。
J Cardiovasc Electrophysiol. 2022 Nov;33(11):2250-2260. doi: 10.1111/jce.15657. Epub 2022 Sep 18.
8
First-line treatment of persistent and long-standing persistent atrial fibrillation with single-stage hybrid ablation: a 2-year follow-up study.一期杂交消融治疗持续性及长期持续性心房颤动:2 年随访研究。
Europace. 2021 Oct 9;23(10):1568-1576. doi: 10.1093/europace/euab093.
9
Vein of Marshall ethanol infusion for persistent atrial fibrillation: VENUS and MARS clinical trial design.Marshall 静脉乙醇注射治疗持续性心房颤动:VENUS 和 MARS 临床试验设计。
Am Heart J. 2019 Sep;215:52-61. doi: 10.1016/j.ahj.2019.04.022. Epub 2019 May 11.
10
Comparing Safety and Efficacy of Irrigated Radiofrequency Catheter Ablation Versus Combined Cryoballoon and Catheter Ablation for Persistent Atrial Fibrillation.比较灌注式射频导管消融与冷冻球囊联合导管消融治疗持续性心房颤动的安全性和有效性。
J Atr Fibrillation. 2013 Oct 31;6(3):924. doi: 10.4022/jafib.924. eCollection 2013 Oct-Nov.